Apoptosis is an innate defense function of macrophages against Mycobacterium tuberculosis
- PMID: 21307848
- PMCID: PMC3155700
- DOI: 10.1038/mi.2011.3
Apoptosis is an innate defense function of macrophages against Mycobacterium tuberculosis
Abstract
Two different forms of death are commonly observed when Mycobacterium tuberculosis (Mtb)-infected macrophages die: (i) necrosis, a death modality defined by cell lysis and (ii) apoptosis, a form of death that maintains an intact plasma membrane. Necrosis is a mechanism used by bacteria to exit the macrophage, evade host defenses, and spread. In contrast, apoptosis of infected macrophages is associated with diminished pathogen viability. Apoptosis occurs when tumor necrosis factor activates the extrinsic death domain pathway, leading to caspase-8 activation. In addition, mitochondrial outer membrane permeabilization leading to activation of the intrinsic apoptotic pathway is required. Both pathways lead to caspase-3 activation, which results in apoptosis. We have recently demonstrated that during mycobacterial infection, cell death is regulated by the eicosanoids, prostaglandin E(2) (proapoptotic) and lipoxin (LX)A(4) (pronecrotic). Although PGE(2) protects against necrosis, virulent Mtb induces LXA(4) and inhibits PGE(2) production. Under such conditions, mitochondrial inner membrane damage leads to macrophage necrosis. Thus, virulent Mtb subverts eicosanoid regulation of cell death to foil innate defense mechanisms of the macrophage.
Conflict of interest statement
The authors declared no conflict of interest.
Figures




Comment in
-
The impact of mucosal infections on acquisition and progression of tuberculosis.Mucosal Immunol. 2011 May;4(3):246-51. doi: 10.1038/mi.2011.11. Epub 2011 Mar 16. Mucosal Immunol. 2011. PMID: 21412228 Free PMC article. Review.
Similar articles
-
Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy?Nat Rev Microbiol. 2010 Sep;8(9):668-74. doi: 10.1038/nrmicro2387. Epub 2010 Aug 2. Nat Rev Microbiol. 2010. PMID: 20676146 Free PMC article. Review.
-
Dying to live: how the death modality of the infected macrophage affects immunity to tuberculosis.Adv Exp Med Biol. 2013;783:103-20. doi: 10.1007/978-1-4614-6111-1_6. Adv Exp Med Biol. 2013. PMID: 23468106 Free PMC article. Review.
-
Mycobacterium tuberculosis Exploits Focal Adhesion Kinase to Induce Necrotic Cell Death and Inhibit Reactive Oxygen Species Production.Front Immunol. 2021 Oct 20;12:742370. doi: 10.3389/fimmu.2021.742370. eCollection 2021. Front Immunol. 2021. PMID: 34745115 Free PMC article.
-
Lipids, apoptosis, and cross-presentation: links in the chain of host defense against Mycobacterium tuberculosis.Microbes Infect. 2011 Aug;13(8-9):749-56. doi: 10.1016/j.micinf.2011.03.002. Epub 2011 Mar 31. Microbes Infect. 2011. PMID: 21458584 Free PMC article. Review.
-
Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair.Nat Immunol. 2009 Aug;10(8):899-906. doi: 10.1038/ni.1758. Epub 2009 Jun 28. Nat Immunol. 2009. PMID: 19561612 Free PMC article.
Cited by
-
Mitochondrial dysfunction in lung ageing and disease.Eur Respir Rev. 2020 Oct 15;29(157):200165. doi: 10.1183/16000617.0165-2020. Print 2020 Sep 30. Eur Respir Rev. 2020. PMID: 33060165 Free PMC article. Review.
-
Hypoxia and classical activation limits Mycobacterium tuberculosis survival by Akt-dependent glycolytic shift in macrophages.Cell Death Discov. 2016 May 30;2:16022. doi: 10.1038/cddiscovery.2016.22. eCollection 2016. Cell Death Discov. 2016. PMID: 27551515 Free PMC article.
-
The tuberculosis necrotizing toxin kills macrophages by hydrolyzing NAD.Nat Struct Mol Biol. 2015 Sep;22(9):672-8. doi: 10.1038/nsmb.3064. Epub 2015 Aug 3. Nat Struct Mol Biol. 2015. PMID: 26237511 Free PMC article.
-
Antigen-specific CD8(+) T cells and protective immunity to tuberculosis.Adv Exp Med Biol. 2013;783:141-63. doi: 10.1007/978-1-4614-6111-1_8. Adv Exp Med Biol. 2013. PMID: 23468108 Free PMC article. Review.
-
Insights into innovative therapeutics for drug-resistant tuberculosis: Host-directed therapy and autophagy inducing modified nanoparticles.Int J Pharm. 2022 Jun 25;622:121893. doi: 10.1016/j.ijpharm.2022.121893. Epub 2022 Jun 6. Int J Pharm. 2022. PMID: 35680110 Free PMC article.
References
-
- Schlesinger LS, Kaufman TM, Iyer S, Hull SR, Marchiando LK. Differences in mannose receptor-mediated uptake of lipoarabinomannan from virulent and attenuated strains of Mycobacterium tuberculosis by human macrophages. J Immunol. 1996;157:4568–4575. - PubMed
-
- Sturgill-Koszycki S, et al. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase [see comments] [published erratum appears in Science 1994 11 March;263(5152):1359] Science. 1994;263:678–681. - PubMed
-
- Chen M, Gan H, Remold HG. A mechanism of virulence: virulent Mtb tuberculosis strain H37Rv but not attenuated H37Ra causes significant mitochondrial inner membrane disruption in macrophages leading to necrosis. J Immunol. 2006;176:3707–3716. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials